Biopharma Stock Breaking News - BioNTech (Nasdaq: BNTX) and DualityBio Receive FDA Fast Track Designation
Biopharma Stock Breaking News - BioNTech (Nasdaq: BNTX) and DualityBio Receive FDA Fast Track Designation
Source: investorideas.com
Page 3 - Iontech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Iontech Today - Breaking & Trending Today
Bragar Eagel & Squire, P.C. Reminds Investors That Class
NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...
Source: globenewswire.com
Projectmates Construction Program Management Software Wins
Constructech Recognizes Projectmates Software as a 2024 Trusted Product...
Source: globenewswire.com
BioNTech challenges AstraZeneca with breast cancer precision drug trial
BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo. COVID-19 vaccine maker BioNTech, which is renewing its focus on its traditional roots in oncology, said in a joint statement with China's Duality that their drug would be tested on women with a certain type of advanced breast cancer with low levels of a cell surface receptor known as HER2. Partners Astra and Daiichi have taken the concept further with their l...
Source: yahoo.com
Time To Worry? Analysts Are Downgrading Their BioNTech SE (NASDAQ:BNTX) Outlook
Market forces rained on the parade of BioNTech SE ( NASDAQ:BNTX ) shareholders today, when the analysts downgraded...
Source: yahoo.com